The anti-inflammatory effects of macrolides in cystic fibrosis.
Jaffè
A
A
Royal Brompton and Harefield NHS Trust, London, England.
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001422:Bacterial Adhesion; D018441:Biofilms; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000209:etiology; D016207:Cytokines; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000209:etiology; D018942:Macrolides; D009504:Neutrophils; D011550:Pseudomonas aeruginosa
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000900:Anti-Bacterial Agents; D016207:Cytokines; D018942:Macrolides